Singapore markets close in 4 hours 2 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
340.88-4.86 (-1.41%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5131.81B
Enterprise value 3124.42B
Trailing P/E 40.82
Forward P/E 111.25
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)19.20
Price/book (mrq)19.66
Enterprise value/revenue 317.73
Enterprise value/EBITDA 731.63

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3385.04%
S&P500 52-week change 337.51%
52-week high 3497.49
52-week low 366.23
50-day moving average 3374.08
200-day moving average 3287.28

Share statistics

Avg vol (3-month) 316.06M
Avg vol (10-day) 37.44M
Shares outstanding 5403.65M
Implied shares outstanding 6N/A
Float 8344.72M
% held by insiders 19.65%
% held by institutions 157.17%
Shares short (14 Oct 2021) 414.8M
Short ratio (14 Oct 2021) 41.03
Short % of float (14 Oct 2021) 45.01%
Short % of shares outstanding (14 Oct 2021) 43.67%
Shares short (prior month 14 Sep 2021) 414.3M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 49.79%
Operating margin (ttm)54.39%

Management effectiveness

Return on assets (ttm)24.30%
Return on equity (ttm)72.43%

Income statement

Revenue (ttm)7.02B
Revenue per share (ttm)17.62
Quarterly revenue growth (yoy)6,398.50%
Gross profit (ttm)-574.88M
EBITDA 3.92B
Net income avi to common (ttm)3.49B
Diluted EPS (ttm)8.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.99B
Total cash per share (mrq)19.8
Total debt (mrq)603M
Total debt/equity (mrq)8.99
Current ratio (mrq)1.24
Book value per share (mrq)16.64

Cash flow statement

Operating cash flow (ttm)9.19B
Levered free cash flow (ttm)8.16B